Related references
Note: Only part of the references are listed.Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups
David W. Ellison et al.
ACTA NEUROPATHOLOGICA (2011)
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Jake E. Delmore et al.
CELL (2011)
The F-box protein Fbw7 is required for cerebellar development
Anett Jandke et al.
DEVELOPMENTAL BIOLOGY (2011)
Temozolomide induced c-Myc-mediated apoptosis via Akt signalling in MGMT expressing glioblastoma cells
Maria De Salvo et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2011)
Phase I Trial of MK-0752 in Children With Refractory CNS Malignancies: A Pediatric Brain Tumor Consortium Study
Maryam Fouladi et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Integrative Genomic Analysis of Medulloblastoma Identifies a Molecular Subgroup That Drives Poor Clinical Outcome
Yoon-Jae Cho et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Medulloblastoma Comprises Four Distinct Molecular Variants
Paul A. Northcott et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
The MYCN oncogene and differentiation in neuroblastoma
Ulrica K. Westermark et al.
SEMINARS IN CANCER BIOLOGY (2011)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
Small-Molecule Inhibitors of Phosphatidylinositol 3-Kinase/Akt Signaling Inhibit Wnt/beta-Catenin Pathway Cross-Talk and Suppress Medulloblastoma Growth
Ninib Baryawno et al.
CANCER RESEARCH (2010)
Dexamethasone Destabilizes Nmyc to Inhibit the Growth of Hedgehog-Associated Medulloblastoma
Vivi M. Heine et al.
CANCER RESEARCH (2010)
Tipping the Balance: Cdk2 Enables Myc to Suppress Senescence
Per Hydbring et al.
CANCER RESEARCH (2010)
Sleeping Beauty-Mediated Somatic Mutagenesis Implicates CSF1 in the Formation of High-Grade Astrocytomas
Aaron M. Bender et al.
CANCER RESEARCH (2010)
c-Myc Regulates Transcriptional Pause Release
Peter B. Rahl et al.
CELL (2010)
Pleiotropic role for MYCN in medulloblastoma
Fredrik J. Swartling et al.
GENES & DEVELOPMENT (2010)
Disabling c-Myc in Childhood Medulloblastoma and Atypical Teratoid/Rhabdoid Tumor Cells by the Potent G-Quadruplex Interactive Agent S2T1-6OTD
Tarek Shalaby et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Subtypes of medulloblastoma have distinct developmental origins
Paul Gibson et al.
NATURE (2010)
Cdk2 suppresses cellular senescence induced by the c-myc oncogene
Stefano Campaner et al.
NATURE CELL BIOLOGY (2010)
Fbw7 controls neural stem cell differentiation and progenitor apoptosis via Notch and c-Jun
Joerg D. Hoeck et al.
NATURE NEUROSCIENCE (2010)
Canonical Notch signaling is not required for the growth of Hedgehog pathway-induced medulloblastoma
E. Julian et al.
ONCOGENE (2010)
Myc proteins as therapeutic targets
W. C. Gustafson et al.
ONCOGENE (2010)
Notch signaling is not essential in sonic hedgehog-activated medulloblastoma
B. A. Hatton et al.
ONCOGENE (2010)
Phosphorylation by Cdk2 is required for Myc to repress Ras-induced senescence in cotransformation
Per Hydbring et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
c-myc and N-myc promote active stem cell metabolism and cycling as architects of the developing brain
Alice Wey et al.
ONCOTARGET (2010)
MYC as a regulator of ribosome biogenesis and protein synthesis
Jan van Riggelen et al.
NATURE REVIEWS CANCER (2010)
Malignant Gliomas with Primitive Neuroectodermal Tumor-like Components: A Clinicopathologic and Genetic Study of 53 Cases
Arie Perry et al.
BRAIN PATHOLOGY (2009)
Whole-Body Sleeping Beauty Mutagenesis Can Cause Penetrant Leukemia/Lymphoma and Rare High-Grade Glioma without Associated Embryonic Lethality
Lara S. Collier et al.
CANCER RESEARCH (2009)
The TRIM-NHL Protein TRIM32 Activates MicroRNAs and Prevents Self-Renewal in Mouse Neural Progenitors
Jens C. Schwamborn et al.
CELL (2009)
N-myc alters the fate of preneoplastic cells in a mouse model of medulloblastoma
Jessica D. Kessler et al.
GENES & DEVELOPMENT (2009)
Outcome Prediction in Pediatric Medulloblastoma Based on DNA Copy-Number Aberrations of Chromosomes 6q and 17q and the MYC and MYCN Loci
Stefan Pfister et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
Targeting the ubiquitin system in cancer therapy
Daniela Hoeller et al.
NATURE (2009)
Targeting proteins for degradation
Erin K. Schrader et al.
NATURE CHEMICAL BIOLOGY (2009)
Comparative analyses of gene copy number and mRNA expression in glioblastoma multiforme tumors and xenografts
J. Graeme Hodgson et al.
NEURO-ONCOLOGY (2009)
Glioblastoma Subclasses Can Be Defined by Activity among Signal Transduction Pathways and Associated Genomic Alterations
Cameron Brennan et al.
PLOS ONE (2009)
Identifying candidate genes involved in brain tumor formation
Fredrik Johansson Swartling
UPSALA JOURNAL OF MEDICAL SCIENCES (2009)
Facilitating replication under stress: an oncogenic function of MYC?
Steffi Herold et al.
NATURE REVIEWS CANCER (2009)
c-MYC amplification and expression in astrocytic tumors
Mario Henrique Faria et al.
ACTA NEUROPATHOLOGICA (2008)
Acquisition of granule neuron precursor identity is a critical determinant of progenitor cell competence to form Shh-induced medulloblastoma
Ulrich Schueller et al.
CANCER CELL (2008)
Medulloblastoma can be initiated by deletion of patched in lineage-restricted progenitors or stem cells
Zeng-Jie Yang et al.
CANCER CELL (2008)
p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation
Hongwu Zheng et al.
NATURE (2008)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
Malignant gliomas in adults
Patrick Y. Wen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
C-Myc and β-catenin cooperate with loss of p53 to generate multiple members of the primitive neuroectodermal tumor family in mice
H. Momota et al.
ONCOGENE (2008)
Integrated Genomics Identifies Five Medulloblastoma Subtypes with Distinct Genetic Profiles, Pathway Signatures and Clinicopathological Features
Marcel Kool et al.
PLOS ONE (2008)
c-Myc Is Required for Maintenance of Glioma Cancer Stem Cells
Jialiang Wang et al.
PLOS ONE (2008)
Inhibitors of mammalian target of rapamycin downregulate MYCN protein expression and inhibit neuroblastoma growth in vitro and in vivo
J. I. Johnsen et al.
ONCOGENE (2008)
Reprogramming of human somatic cells to pluripotency with defined factors
In-Hyun Park et al.
NATURE (2008)
MYC - TIMELINE Reflecting on 25 years with MYC
Natalie Meyer et al.
NATURE REVIEWS CANCER (2008)
Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts
Masato Nakagawa et al.
NATURE BIOTECHNOLOGY (2008)
Mechanisms of transcription factor deregulation in lymphoid cell transformation
J. O'Neil et al.
ONCOGENE (2007)
Improved low molecular weight Myc-Max inhibitors
Huabo Wang et al.
MOLECULAR CANCER THERAPEUTICS (2007)
The 2007 WHO classification of tumours of the central nervous system
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
The ubiquitin-specific protease USP28 is required for MYC stability
Nikita Popov et al.
NATURE CELL BIOLOGY (2007)
Inhibition of CDK1 as a potential therapy for tumors over-expressing MYC
Andrei Goga et al.
NATURE MEDICINE (2007)
Resilience to transformation and inherent genetic and functional stability of adult neural stem cells ex vivo
Chiara Foroni et al.
CANCER RESEARCH (2007)
Genetic alterations in mouse medulloblastomas and generation of tumors De novo from primary cerebellar granule neuron precursors
Frederique Zindy et al.
CANCER RESEARCH (2007)
Wnt/Wingless pathway activation and chromosome 6 loss characterize a distinct molecular sub-group of medulloblastomas associated with a favorable prognosis
Steven C. Clifford et al.
CELL CYCLE (2006)
A small-molecule c-Myc inhibitor, 10058-F4, induces cell-cycle arrest, apoptosis, and myeloid differentiation of human acute myeloid leukemia
Ming-Jer Huang et al.
EXPERIMENTAL HEMATOLOGY (2006)
N-myc is an essential downstream effector of Shh signaling during both normal and neoplastic cerebellar growth
Beryl A. Hatton et al.
CANCER RESEARCH (2006)
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors
Kazutoshi Takahashi et al.
CELL (2006)
Inhibition of phosphatidylinositol 3-kinase destabilizes Mycn protein and blocks malignant progression in neuroblastoma
Louis Chesler et al.
CANCER RESEARCH (2006)
Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors
Francesco Marampon et al.
MOLECULAR CANCER (2006)
N-Myc and the cyclin-dependent kinase inhibitors p18Ink4c and P27Kip1 coordinately regulate cerebellar development
Frederique Zindy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The Myc oncoprotein as a therapeutic target for human cancer
Marina Vita et al.
SEMINARS IN CANCER BIOLOGY (2006)
Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors
Xing Fan et al.
CANCER RESEARCH (2006)
Myc influences global chromatin structure
Paul S. Knoepfler et al.
EMBO JOURNAL (2006)
A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma
Qi-Wen Fan et al.
CANCER CELL (2006)
Genornics identifies medulloblastoma subgroups that are enriched for specific genetic alterations
MC Thompson et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Brain transplantation of human neural stem cells transduced with tyrosine hydroxylase and GTP cyclohydrolase 1 provides functional improvement in animal models of Parkinson disease
SU Kim et al.
NEUROPATHOLOGY (2006)
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis
HS Phillips et al.
CANCER CELL (2006)
N-myc can substitute for insulin-like growth factor signalling in a mouse mode of sonic hedgehog-induced medulloblastoma
SR Browd et al.
CANCER RESEARCH (2006)
c-Myc phosphorylation is required for cellular response to oxidative stress
B Benassi et al.
MOLECULAR CELL (2006)
c-Myc overexpression causes anaplasia in medulloblastoma
D Stearns et al.
CANCER RESEARCH (2006)
Cancer gene discovery in solid tumours using transposon-based somatic mutagenesis in the mouse
LS Collier et al.
NATURE (2005)
Mammalian mutagenesis using a highly mobile somatic Sleeping Beauty transposon system
AJ Dupuy et al.
NATURE (2005)
The Cdk1 complex plays a prime role in regulating N-myc phosphorylation and turnover in neural precursors
SK Sjostrom et al.
DEVELOPMENTAL CELL (2005)
p53-dependent transcriptional repression of c-myc is required for G(1) cell cycle arrest
JSL Ho et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Histopathological and molecular prognostic markers in medulloblastoma: c-myc, N-myc, TrkC, and anaplasia
CG Eberhart et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2004)
Correlation of amplification and overexpression of the c-myc oncogene in high-grade breast cancer:: FISH, in situ hybridisation and immunohistochemical analyses
J Blancato et al.
BRITISH JOURNAL OF CANCER (2004)
A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells
E Yeh et al.
NATURE CELL BIOLOGY (2004)
Medulloblastoma: signalling a change in treatment
RJ Gilbertson
LANCET ONCOLOGY (2004)
AKT activity determines sensitivity to mammalian target of rapamycin (mTOR) inhibitors by regulating cyclin D1 and c-myc expression
JF Gera et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Identification of candidate cancer-causing genes in mouse brain tumors by retroviral tagging
FK Johansson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Opinion - Analysis of genomic targets reveals complex functions of MYC
JH Patel et al.
NATURE REVIEWS CANCER (2004)
Hedgehog and PI-3 kinase signaling converge on Nmyc1 to promote cell cycle progression in cerebellar neuronal precursors
AM Kenney et al.
DEVELOPMENT (2004)
Overexpression of c-MYC promotes an undifferentiated phenotype in cultured astrocytes and allows elevated Ras and Akt signaling to induce gliomas from GFAP-expressing cells in mice
Andrew B. Lassman et al.
NEURON GLIA BIOLOGY (2004)
Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7
M Yada et al.
EMBO JOURNAL (2004)
Phosphorylation by glycogen synthase kinase-3 controls c-Myc proteolysis and subnuclear localization
MA Gregory et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Low molecular weight inhibitors of Myc-Max interaction and function
XY Yin et al.
ONCOGENE (2003)
The F-Box protein Skp2 participates in c-Myc protelosornal degradation and acts as a cofactor for c-Myc-regulated transcription
N von der Lehr et al.
MOLECULAR CELL (2003)
Skp2 regulates Myc protein stability and activity
SY Kim et al.
MOLECULAR CELL (2003)
Myc represses differentiation-induced p21CIP1 expression via Miz-1-dependent interaction with the p21 core promoter
SQ Wu et al.
ONCOGENE (2003)
Nmyc upregulation by sonic hedgehog signaling promotes proliferation in developing cerebellar granule neuron precursors
AM Kenney et al.
DEVELOPMENT (2003)
A role for c-Myc in the regulation of ribosomal RNA processing
I Schlosser et al.
NUCLEIC ACIDS RESEARCH (2003)
N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation
PS Knoepfler et al.
GENES & DEVELOPMENT (2002)
Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors
JR Pollack et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
MxiI inhibits the proliferation of U87 glioma cells through down-regulation of cyclin B1 gene expression
I Manni et al.
BRITISH JOURNAL OF CANCER (2002)
Prediction of central nervous system embryonal tumour outcome based on gene expression
SL Pomeroy et al.
NATURE (2002)
MYC expression promotes the proliferation of neural progenitor cells in culture and in vivo
D Fults et al.
NEOPLASIA (2002)
Comparative genomic hybridization detects an increased number of chromosomal alterations in large cell/anaplastic medulloblastomas
CG Eberhart et al.
BRAIN PATHOLOGY (2002)
Detection of multiple gene amplifications in glioblastoma multiforme using array-based comparative genomic hybridization
ABY Hui et al.
LABORATORY INVESTIGATION (2001)
Skp2 is oncogenic and overexpressed in human cancers
M Gstaiger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Repression of p15INK4b expression by Myc through association with Miz-1
P Staller et al.
NATURE CELL BIOLOGY (2001)
N-myc enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesis
K Boon et al.
EMBO JOURNAL (2001)
Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability
R Sears et al.
GENES & DEVELOPMENT (2000)
Recognition of the polyubiquitin proteolytic signal
JS Thrower et al.
EMBO JOURNAL (2000)
Establishment and properties of a growth factor-dependent, perpetual neural stem cell line from the human CNS
A Villa et al.
EXPERIMENTAL NEUROLOGY (2000)
Share Paper
